China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Former envoy pushes Sino-EU cooperation on climate change
- China praised for its green transition
- Report hails rural growth in Xizang
- China's tech-empowered grain farming bolsters food security
- Joint global effort needed to foster fair low-carbon economy
- Z-20T helicopter dazzles in Tianjin, showcasing broad combat versatility
